Ncats DPI TDB infuse health equity preclinical development
Ended Awarded Last action
- Contract number
- 75N95022F00142
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1 Part of The Mitre Corporation
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,864,415
Award facts
- Opportunity
-
- 75N95022R00068 Solicitation number
- Contract value 100% obligated
- $1,864,415.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West McLean, VA 22102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $252,503 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $12,833 | |
| Funding Only Action | $0 | |
| Exercise an Option | $358,625 | |
| Exercise an Option | $470,227 | |
| Other Administrative Action | $0 | |
| Original award | $770,227 |
About this award
This is a federal contract award (Contract ID: 75FCMC18D0047|75N95022F00142) from the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the prime contractor The Mitre Corporation. The contract is for NCATS' DPI TDB INFUSE HEALTH EQUITY PRECLINICAL DEVELOPMENT, and has a ceiling value of $1,864,415.00. It is a delivery order contract with a cost-plus-fixed-fee pricing type, and the ultimate completion date is January 22, 2025. The contract does not have a set-aside designation. The Mitre Corporation is a non-profit organization that operates federally funded research and development centers (FFRDCs) and frequently collaborates with subcontractors to deliver a range of technical services to government agencies. Mitre holds a significant $2 billion single-award IDIQ contract with the Centers for Medicare and Medicaid Services (CMS) for the CMS Alliance to Modernize Healthcare (HEALTH) FFRDC program, under which this award was likely issued.
Quick answers
Who was awarded contract 75N95022F00142?
75N95022F00142 was awarded to The Mitre Corporation by National Institute on Drug Abuse (National Institutes of Health) on September 12, 2022.
How much is contract 75N95022F00142 worth?
The government has obligated $1,864,415 on 75N95022F00142.
Which agency awarded contract 75N95022F00142?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00142, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95022F00142 an order under another contract?
Yes. 75N95022F00142 is a delivery order under 75FCMC18D0047, an indefinite delivery contract.
Was contract 75N95022F00142 competed?
The extent of competition for 75N95022F00142 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award